Mild-to-Moderate Symptoms during the First Year of Antiretroviral Therapy Worsen Quality of Life in HIV-Infected Individuals
Author(s) -
Sharon Mannheimer,
Nicholas Wold,
Edward M. Gardner,
Edward E. Telzak,
Katherine Huppler Hullsiek,
Margaret A. Chesney,
Albert W. Wu,
Rodger D. MacArthur,
John P. Matts,
Gerald Friedland
Publication year - 2008
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/528859
Subject(s) - medicine , quality of life (healthcare) , antiretroviral therapy , human immunodeficiency virus (hiv) , sida , viral disease , young adult , viral load , pediatrics , immunology , nursing
Symptoms and quality of life were assessed among human immunodeficiency virus (HIV)-infected individuals initiating their first course of antiretroviral therapy. Symptoms, which were mostly mild or moderate, were common in the first year and significantly affected the patients' quality of life. Quality of life was inversely related to the number of symptoms and in the change in the number of symptoms from baseline.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom